Clinical trial NCT02970422: Chronic Obstructive Pulmonary Disease Patient Preferences Survey
Official title: COPD Patient Preferences, Activities, and Participation Survey
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Keywords: Survey
Priorities
Activities
Participation
Lead sponsor: McGill University
Sponsor class: OTHER
Collaborators: name: AstraZeneca
First posted: 2016-11-22
Enrollment: 200
Sex: ALL
Minimum age (years): 40
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Adults living with chronic obstructive pulmonary disease (COPD).

Brief summary: The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.


Eligibility criteria: Inclusion Criteria:

* Clinical diagnosis of COPD
* English or French speaking
* Patient at one of the three participating sites with medical chart

Exclusion Criteria:

* No diagnosis of COPD by a healthcare professional
* Unable to communicate in English or French
* Unable to provide informed consent
* No medical chart information at one of the three participating sites

Primary outcomes:
measure: Number of Participants Who Prioritized Healthcare Topics
timeFrame: Baseline
measure: Number of Participants Who Prioritized Research Topics
timeFrame: Baseline
measure: Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
timeFrame: Baseline
Secondary outcomes:
measure: Forced Expiratory Volume in 1-sec (FEV1)
timeFrame: Baseline
measure: FEV1/FVC
timeFrame: Baseline
measure: Modified Medical Research Council Questionnaire on Breathlessness
timeFrame: Baseline
measure: COPD Assessment Test
timeFrame: Baseline
measure: Godin Leisure Time Physical Activity Questionnaire
timeFrame: Baseline
measure: Satisfaction of Life Questionnaire
timeFrame: Baseline
measure: Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months
timeFrame: baseline
Other outcomes:
Locations:
city: Montreal
country: Canada
facility: Montreal Chest Institute of the McGill University Health Center (MUHC)
state: Quebec
Study officials:
affiliation: McGill University
name: Dennis Jensen, Ph.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: McGill University
name: Shane N Sweet, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: